FibroTrap™ (Debio 1561)

FIRST sample preparation method enabling early detection of infections

FibroTrap™ is a fibrinogen-based technology able to concentrate microorganisms (bacteria and yeasts) from whole blood in about 60 minutes.
Combined with a molecular method, FibroTrap™ accelerates the identification of pathogen and resistance genes in 3 hours, compared to 24-48 h or more with conventional methods. Aside being exceptionally fast, this unique clotting-based technology is also characterized by a high reliability and simplicity of utilization. Using the FibroTrap™ technology will increase the chances of saving lives and providing the right treatment, for the right patient, in a timely manner.

Product Snapshot


Detection of multiple forms of infection

Being researched in:

  • Blood stream infections and sepsis

In short

FibroTrap™ abilities have been confirmed by a clinical verification study conducted in collaboration with Prof. Bergeron at the Centre de recherche en infectiologie and Centre de recherche du CHU de Québec-Université Laval, Québec City, Québec, Canada

This technology is F.I.R.S.T.: Fast, Innovative, Reliable, Simple, Technology-agnostic

Focus on the Technology

FibroTrap™ allows the efficient concentration of microorganisms from 5 ml blood samples in approximately 60 minutes. The whole process consists of two simple steps: 1) capture: the microorganisms are trapped into a small clot that is anchoring around a pin structure in a single reaction 2) lysis: the clot is lysed to release the microorganisms in a small volume of liquid. This technology integrates seamlessly the workflow of standard diagnostic and is not affected by common treatment regimens (e.g., anticoagulant, antiplatelet, antipyretic and cancer treatment)